Physician

Priya J Bansal, M.D.,

According to 2025 Medicare claims, Priya Bansal, M.D., (NPI: 1811970486) practices allergy/immunology in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is ASTHMA AND ALLERGY WELLNESS CENTER LLC (NPI: 1386115129; TIN: 832455098) and primary practice location at 60175-4827.

Bansal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 140 traditional Medicare patients, billed 13,465 HCPCS/CPT codes, and received $334,524 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 999 prescription claims across 145 beneficiaries totaling $1,451,491 in drug costs, led by Takhzyro (Lanadelumab-Flyo). DME data shows 289 claims. Open Payments data shows 431 records totaling $219,985. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $22,565 to $334,524. Similarly, Part D prescription costs have moved sharply higher in recent years, from $248,571 to $1,451,491. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,812 and ending at $5,602.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	123	1,591	$22,565
2016	120	2,512	$36,433
2017	117	2,043	$30,558
2018	144	2,822	$36,451
2019	78	5,731	$129,717
2020	82	5,373	$148,441
2021	112	7,917	$213,535
2022	114	6,275	$190,309
2023	135	9,177	$241,391
2024	140	13,465	$334,524

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	88	771	$248,571
2016	80	660	$279,387
2017	78	541	$126,891
2018	82	660	$165,135
2019	102	717	$278,072
2020	88	943	$607,461
2021	112	965	$1,060,934
2022	118	834	$677,890
2023	131	842	$1,552,252
2024	145	999	$1,451,491

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$69,337
2016	N/R	41	$35,947
2017	N/R	150	$148,289
2018	N/R	146	$207,377
2019	N/R	113	$100,573
2020	N/R	119	$143,790
2021	N/R	205	$237,868
2022	N/R	232	$259,190
2023	N/R	241	$280,578
2024	N/R	289	$323,446

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	43	43	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	110	240	$94
94010	Test to measure expiratory airflow and volume	33	34	$22
95012	Test to measure the level of nitric oxide gas	70	100	$15
96160	Administration and interpretation of patient-focused health risk assessment	65	145	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Takhzyro	Lanadelumab-Flyo	19	700	$956,043
Sucraid	Sacrosidase	13	372	$143,511
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	3,420	$70,779
Xhance	Fluticasone Propionate	30	1,320	$44,180
Arnuity Ellipta	Fluticasone Furoate	60	2,400	$19,699

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	38	$138,673
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	38	$92,976
J1557	Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$68,291
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	11	$9,766
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	17	$8,241

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	431	$219,985	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Priya J. Bansal, M.D., ?

Tedicare shows public-source Medicare data for Priya J. Bansal, M.D., (NPI 1811970486), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Priya J. Bansal, M.D., have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Priya J. Bansal, M.D., ?

Priya J. Bansal, M.D., is linked to ASTHMA AND ALLERGY WELLNESS CENTER LLC (billing NPI 1386115129) in the available physician profile data.

Does Priya J. Bansal, M.D., have Open Payments data?

Priya J. Bansal, M.D., has 431 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.